Improved health-related quality of life with SSRIs and other antidepressants

Pharmacotherapy

Volumn 21, Issue 2, 2001, Pages 189-194

  Taylor, A T ^a   Spruill, W J ^a   Longe, R L ^a   Wade, W E ^a   Wagner, P J ^a  

^a MEDICAL COLLEGE OF GEORGIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMFEBUTAMONE; AMITRIPTYLINE; ANTIDEPRESSANT AGENT; DESIPRAMINE; DOXEPIN; FLUOXETINE; NEFAZODONE; NORTRIPTYLINE; PAROXETINE; SEROTONIN UPTAKE INHIBITOR; SERTRALINE; TRAZODONE; TRICYCLIC ANTIDEPRESSANT AGENT;

ADULT; AGED; ARTICLE; COMMUNITY CARE; DEPRESSION; FEMALE; HEALTH SURVEY; HUMAN; MAJOR CLINICAL STUDY; MALE; MENTAL DISEASE; OUTCOMES RESEARCH; PATIENT CARE; PHARMACIST; QUALITY OF LIFE;

ADULT; ANTIDEPRESSIVE AGENTS; BODY WEIGHT; CROSS-SECTIONAL STUDIES; DEPRESSION; FEMALE; HUMANS; MALE; MIDDLE AGED; PHARMACISTS; QUALITY OF LIFE; SEROTONIN UPTAKE INHIBITORS; TREATMENT OUTCOME;

EID: 0035146445     PISSN: 02770008     EISSN: None     Source Type: Journal    
DOI: 10.1592/phco.21.2.189.34102     Document Type: Article

References (11)

1. The functioning and wellbeing of depressed patients: Results from the medical outcome study
2. Depression, disability days and days lost from work in a prospective epidemiologic survey
3. Disability and depression among high utilizers of health care
4. The course of depression in adult outpatients: Results from the medical outcomes study
5. The economic burden of depression in 1990
6. Health care costs of primary care patients with recognized depression
7. Cost-effectiveness comparisons using "real world" randomized trials: The case of new antidepressant drugs
8. Enhancing outcomes research - The experience of a community pharmacist research network
9. Depression, health-related quality of life, and medical cost outcomes of receiving recommended levels of antidepressant treatment